{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Beta-Blocker vs. Calcium-Channel Blocker in HCM ","description":" In this week\u2019s View, Dr. Eagle\u202flooks&amp;nbsp;at&amp;nbsp;the differential&amp;nbsp;effect of&amp;nbsp;bisoprolol versus&amp;nbsp;verapamil&amp;nbsp;in nonobstructive&amp;nbsp;hypertrophic cardiomyopathy (HCM)&amp;nbsp;treatment.&amp;nbsp;He then\u202fexplores&amp;nbsp;lower heart failure (HF) hospitalization risk in patients with type 2 diabetes, comparing GLP-1RAs to DPP-4 inhibitors and similar outcomes with SGLT-2 inhibitors.&amp;nbsp;Dr. Eagle&amp;nbsp;then&amp;nbsp;examines&amp;nbsp;the&amp;nbsp;use&amp;nbsp;of shared&amp;nbsp;decision-making and&amp;nbsp;decision&amp;nbsp;aids&amp;nbsp;in&amp;nbsp;percutaneous&amp;nbsp;left atrial&amp;nbsp;appendage&amp;nbsp;occlusion (LAAO).&amp;nbsp;&amp;nbsp;Finally,&amp;nbsp;the&amp;nbsp;iModern&amp;nbsp;trial,&amp;nbsp;which compares&amp;nbsp;immediate percutaneous coronary intervention (PCI) guided by instantaneous wave-free ratio (iFR) and deferred PCI guided by cardiac stress magnetic resonance imaging (MRI) in patients with STEMI and multivessel disease, is discussed.&amp;nbsp;   \u202fSubscribe to Eagle\u2019s Eye View\u202f\u202f&amp;nbsp;&amp;nbsp;  ","author_name":"Eagle's Eye View: Your Weekly CV Update From ACC.org","author_url":"http:\/\/www.acc.org","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/40397335\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/199493630"}